Rapid communication Open Access
Like 0


We present a European Union/European Economic Area-wide overview of the changes in consumption of antibacterials for systemic use (ATC J01) in the community between 2019 and 2020 as reported to the European Surveillance of Antimicrobial Consumption Network. Overall antibiotic consumption decreased by 18.3% between 2019 and 2020, the largest annual decrease in the network's two-decade history. We observed a strong association between the level of community antibiotic consumption in 2019 and the size of the decrease between 2019 and 2020.


Article metrics loading...

Loading full text...

Full text loading...



  1. Ullrich A, Schranz M, Rexroth U, Hamouda O, Schaade L, Diercke M, et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 – week 32-2020. Lancet Reg Health Eur. 2021;6:100103.  PMID: 34473285 
  2. Tomczyk S, Taylor A, Brown A, de Kraker MEA, El-Saed A, Alshamrani M, et al. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. J Antimicrob Chemother. 2021;76(11):3045-58.  https://doi.org/10.1093/jac/dkab300  PMID: 34473285 
  3. European Centre for Disease Prevention and Control (ECDC). Antimicrobial consumption in the EU/EEA. Annual epidemiological report 2020. Stockholm: ECDC; 2021.
  4. European Centre for Disease Prevention and Control (ECDC). TESSy, The European Surveillance System. Antimicrobial consumption (AMC) reporting protocol 2021. European Surveillance of Antimicrobial Consumption Network (ESAC-Net) surveillance data for 2020. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/ESAC-net-reporting-protocol-2021.pdf
  5. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2021. WHOCC. No. 2021. Oslo: Norwegian Institute of Public Health. [Accessed: 10 Sep 2021]. Available from: https://www.whocc.no/atc_ddd_index
  6. StataCorp. Stata statistical software: Release 16. College Station: StataCorp LLC; 2019. Available from: www.stata.com
  7. Gagliotti C, Buttazzi R, Ricchizzi E, Di Mario S, Tedeschi S, Moro ML. Community use of antibiotics during the COVID-19 lockdown. Infect Dis (Lond). 2021;53(2):142-4.  https://doi.org/10.1080/23744235.2020.1834139  PMID: 33073645 
  8. Blix HS, Høye S. Use of antibiotics during the COVID-19 pandemic. Tidsskr Nor Laegeforen. 2021;141(4). Norwegian. PMID: 33685110 
  9. Peñalva G, Benavente RS, Pérez-Moreno MA, Pérez-Pacheco MD, Pérez-Milena A, Murcia J, et al. Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care. Clin Microbiol Infect. 2021;27(7):1058-60.  https://doi.org/10.1016/j.cmi.2021.01.021  PMID: 33540117 
  10. Public Health Agency of Sweden and National Veterinary Institute. Swedres-Svarm 2020. Sales of antibiotics and occurrence of resistance in Sweden. ISSN1650-6332. Solna/Uppsala: Public Health Agency of Sweden and National Veterinary Institute; 2021. Available from: https://www.folkhalsomyndigheten.se/contentassets/fb80663bc7c94d678be785e3360917d1/swedres-svarm-2019.pdf
  11. European Centre for Disease Prevention and Control (ECDC). Seasonal influenza. Annual epidemiological report for 2020-2021. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-annual-epidemiological-report-2020-2021
  12. European Centre for Disease Prevention and Control (ECDC) and Joint Research Centre (JRC) of the European Commission. Response measures database (RMD). Stockholm/Brussels: ECDC and JRC of the European Commission. [Accessed: 10 Sep 2021]. Available from: https://covid-statistics.jrc.ec.europa.eu/RMeasures
  13. Adriaenssens N, Bruyndonckx R, Versporten A, Hens N, Monnet D, Molenberghs G et al. Quality appraisal of antibiotic consumption in the community, European Union/European Economic Area, 2009 and 2017. J Antimicrob Chemother. 2021;76(Supplement_2):ii60-7.
  14. Siemieniuk RA, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Kum E, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020;370:m2980.  https://doi.org/10.1136/bmj.m2980  PMID: 32732190 
  15. World Health Organization (WHO). COVID-19 clinical management: living guidance. WHO/2019-nCoV/clinical/2021.1. Geneva: WHO; 25 Jan 2021. Available from: https://apps.who.int/iris/handle/10665/338882
  16. Huttner BD, Catho G, Pano-Pardo JR, Pulcini C, Schouten J. COVID-19: don’t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020;26(7):808-10.  https://doi.org/10.1016/j.cmi.2020.04.024  PMID: 32360446 
  17. Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520-31.  https://doi.org/10.1016/j.cmi.2020.12.018  PMID: 33418017 
  18. European Commission (EC). A European one health action plan against antimicrobial resistance (AMR). Brussels: EC; 2017. Available from: https://ec.europa.eu/health/sites/default/files/antimicrobial_resistance/docs/amr_2017_action-plan.pdf

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error